| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 41.060 | 92.583 | 95.463 | 95.366 | 107.953 | 102.635 | 119.439 | 112.849 | 89.314 | 80.540 |
| Total Income - EUR | 41.060 | 92.583 | 95.463 | 104.876 | 111.918 | 102.645 | 119.439 | 112.849 | 106.669 | 121.273 |
| Total Expenses - EUR | 33.275 | 24.175 | 25.003 | 34.350 | 33.771 | 37.047 | 38.124 | 37.389 | 47.603 | 30.044 |
| Gross Profit/Loss - EUR | 7.784 | 68.408 | 70.461 | 70.526 | 78.148 | 65.599 | 81.315 | 75.460 | 59.066 | 91.229 |
| Net Profit/Loss - EUR | 6.553 | 67.482 | 69.506 | 69.477 | 77.029 | 64.572 | 80.121 | 74.332 | 58.000 | 87.590 |
| Employees | 3 | 5 | 3 | 3 | 2 | 1 | 2 | 1 | 5 | 1 |
Check the financial reports for the company - Gyne San Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 38.852 | 35.274 | 31.975 | 87.943 | 77.286 | 84.788 | 29.220 | 11.194 | -5.706 | 64.825 |
| Current Assets | 11.968 | 38.242 | 43.617 | 33.328 | 36.379 | 14.740 | 11.412 | 32.718 | 33.282 | 1.124 |
| Inventories | 0 | 0 | 0 | 107 | 3.151 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 537 | 0 | 0 | 0 | 57 | 71 | 0 |
| Cash | 11.968 | 38.242 | 43.617 | 32.683 | 33.227 | 14.740 | 11.412 | 32.661 | 33.211 | 1.124 |
| Shareholders Funds | 48.773 | 72.473 | 74.413 | 119.904 | 112.537 | 98.810 | 39.151 | 42.677 | 26.441 | 63.625 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 42 | 41 | 41 | 41 | 40 |
| Debts | 2.047 | 1.042 | 1.179 | 1.367 | 1.128 | 718 | 1.481 | 1.235 | 1.134 | 2.324 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Gyne San Srl